![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 607.51 | MF: C20H14N2O10S3•3Na |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
fibroblast
|
1 gm/L
|
FCTOD7 22,623,1984
|
DNA damage
|
oral | mouse
10 mg/kg
|
MUREAV 519,103,2002
|
sperm morphology
|
mammal (species unspecified)
other cell types
|
8.3 µg/L/76 day- intermittent
|
TOVEFN (2),37,1996
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 8.3 mg/m3 (1-7 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death
TOVEFN (2),37,1996
|
inhalation | rat
lowest published toxic concentration: 1.8 mg/m3 (76 day male)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) Reproductive: Effects on newborn: Sex ratio
TOVEFN (1),38,1998
|
oral | mouse
lowest published toxic dose: 133 gm/kg (28 day male/28 day prior to copulation-28 day after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Behavioral
FCTOD7 44,1651,2006
|
oral | mouse
lowest published toxic dose: 65 gm/kg (28 day male/28 day prior to copulation-28 day after birth)
|
Reproductive: Effects on newborn: Behavioral
|
FCTOD7 44,1651,2006
|
oral | mouse
lowest published toxic dose: 73.54 gm/kg (multigeneration)
|
Reproductive: Effects on newborn: Behavioral
|
FCTOD7 44,1651,2006
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 428 gm/kg/64 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
VPITAR 29,61,1970
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 70 mg/m3
|
Blood: Methemoglobinemia- Carboxhemoglobinemia | Blood: Other changes
TOVEFN (2),37,1996
|
intraperitoneal | mouse
lethal dose (50 percent kill): 1,600 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Behavioral: Coma
FCTXAV 5,187,1967
|
intraperitoneal | rat
lethal dose (50 percent kill): 600 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Behavioral: Coma
FCTXAV 5,187,1967
|
intraperitoneal | rat
lethal dose (50 percent kill): 1,120 mg/kg
|
Behavioral: Excitement
|
TOVEFN (2),37,1996
|
intravenous | rat
lethal dose (50 percent kill): 1 gm/kg
|
N/R
|
SCPHA4 47,39,1979
|
oral | mouse
lowest published lethal dose: 8 gm/kg
|
N/R
|
SCPHA4 47,39,1979
|
oral | mouse
lethal dose (50 percent kill): >10,000 mg/kg
|
Behavioral: Excitement
|
TOVEFN (2),37,1996
|
oral | rat
lethal dose (50 percent kill): >8 gm/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
FCTXAV 5,187,1967
|
oral | rat
lethal dose (50 percent kill): >10,000 mg/kg
|
Behavioral: Excitement
|
TOVEFN (2),37,1996
|
unreported route | rat
lethal dose (50 percent kill): 2 gm/kg
|
N/R
|
NAIZAM 30,179,1979
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 48 mg/m3/61 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOVEFN (2),37,1996
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 48 mg/m3/91 day- intermittent
|
Blood: Methemoglobinemia- Carboxhemoglobinemia
|
TOVEFN (2),37,1996
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 48 mg/m3/14 day- intermittent
|
Blood: Other changes | Blood: Changes in other cell count (unspecified) Blood: Changes in leukocyte (WBC) count
TOVEFN (2),37,1996
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 8.3 mg/m3/122 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Blood: Changes in other cell count (unspecified) Blood: Changes in leukocyte (WBC) count
TOVEFN (2),37,1996
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 8.3 mg/m3/122 day- intermittent
|
Immunological Including Allergic: Increase in cellular immune response | Immunological Including Allergic: Increase in humoral response Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOVEFN (2),37,1996
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 8.3 mg/m3/61 day- intermittent
|
Liver: Liver function tests impaired | Blood: Hemorrhage Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TOVEFN (2),37,1996
|
inhalation | rat
lowest published toxic concentration: 48 mg/m3/17 week- intermittent
|
Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | Liver: Liver function tests impaired Blood: Other changes
TOVEFN (2),34,1996
|
oral | rat
lowest published toxic dose: 143 gm/kg/90 day- continuous
|
Blood: Pigmented or nucleated red blood cells | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
FCTXAV 5,187,1967
|
oral | rat
lowest published toxic dose: 30 gm/kg/30 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Kidney, Ureter, and Bladder: Other changes in urine composition
TOVEFN (2),34,1996
|
oral | rat
lowest published toxic dose: 30,000 mg/kg/30 day- intermittent
|
Vascular: Other changes | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Kidney, Ureter, and Bladder: Other changes in urine composition
TOVEFN (2),37,1996
|
oral | rat
lowest published toxic dose: 30,000 mg/kg/30 day- intermittent
|
Blood: Methemoglobinemia- Carboxhemoglobinemia | Blood: Changes in erythrocyte (RBC) count Blood: Changes in leukocyte (WBC) count
TOVEFN (2),37,1996
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 584,1,2005
|
TOXICOLOGY REVIEW
|
|
HUTOX* -,259,1996
|
TOXICOLOGY REVIEW
|
|
HUTOX* -,259,1996
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: M4494; | Number of Industries 1; Total Number of Facilities 46; Number of Occupations 1; Total Number of Employees Exposed 138
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: M4494 |
Number of Industries 5; Total Number of Facilities 1,035; Number of Occupations 9; Total Number of Employees Exposed 8,379; Total Number of Female Employees Exposed 2,006 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion
|
EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
| ||||
REFERENCES:
CODEN
|
|
REFERENCE
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
HUTOX*
|
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NAIZAM
|
Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu
Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950-
|
SCPHA4
|
Scientia Pharmaceutica. (Oesterreichische Apotheker-Verlagsgesellschaft MBH, Spitalgasse 31,
1094 Vienna 9, Austria) V.1- 1930-
|
TOVEFN
|
Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown
|
VPITAR
|
Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR)
V.1-10, 1932-41; V.11- 1952-
|
| |